These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 31480062)

  • 1. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
    Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
    Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis.
    Hsu A; Mistry H; Lala N; Reagan JL
    Clin Neurol Neurosurg; 2020 Nov; 198():106204. PubMed ID: 32937276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it safe to treat cerebral venous thrombosis with oral rivaroxaban without heparin? A preliminary study from 20 patients.
    Shankar Iyer R; Tcr R; Akhtar S; Muthukalathi K; Kumar P; Muthukumar K
    Clin Neurol Neurosurg; 2018 Dec; 175():108-111. PubMed ID: 30396036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
    Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K
    Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis.
    Lee GKH; Chen VH; Tan CH; Leow AST; Kong WY; Sia CH; Chew NWS; Tu TM; Chan BPL; Yeo LLL; Sharma VK; Tan BYQ
    J Thromb Thrombolysis; 2020 Oct; 50(3):724-731. PubMed ID: 32279216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of direct oral anticoagulants in cerebral venous thrombosis: a systematic review.
    Sheng S; Nalleballe K; Pothineni NV; Sharma R; Brown A; Elkhider H; Ranabothu S; Kapoor N; Patrice KA; Onteddu S
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):501-505. PubMed ID: 32941197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban for the treatment of cerebral venous thrombosis: A case series.
    Rao SK; Ibrahim M; Hanni CM; Suchdev K; Parker D; Rajamani K; Mohamed W
    J Neurol Sci; 2017 Oct; 381():318-320. PubMed ID: 28991706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis.
    Korathanakhun P; Petpichetchian C; Petpichetchian W; Sathirapanya P
    Clin Neurol Neurosurg; 2017 Aug; 159():50-54. PubMed ID: 28535419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience.
    Bajko Z; Maier S; Motataianu A; Filep RC; Stoian A; Andone S; Balasa R
    Acta Neurol Belg; 2022 Feb; 122(1):105-111. PubMed ID: 33733345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis.
    Giles JA; Balasetti VKS; Zazulia AR
    Neurocrit Care; 2021 Dec; 35(3):783-788. PubMed ID: 34046861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Direct Oral Anticoagulants in Cerebral Venous Thrombosis: Meta-Analysis of Randomized Clinical Trials.
    Chen X; Guo L; Lin M
    Clin Appl Thromb Hemost; 2024; 30():10760296241256360. PubMed ID: 38772568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trial Based Rationale for the Successful Use of DOAC in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A Case Report.
    Bando T; Ueno Y; Shimo D; Kuroyama T; Mikami K; Hori S; Hirai O
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105261. PubMed ID: 33066921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
    Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
    J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular and Medical Management of Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis.
    Naik A; Smith E; Dharnipragada R; Catapano JS; Cramer SW; Johnson R; Khanam R; Hassaneen W; Lawton MT; Arnold PM
    World Neurosurg; 2022 Sep; 165():e197-e205. PubMed ID: 35688371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis.
    Nepal G; Kharel S; Bhagat R; Ka Shing Y; Ariel Coghlan M; Poudyal P; Ojha R; Sunder Shrestha G
    Acta Neurol Scand; 2022 Jan; 145(1):10-23. PubMed ID: 34287841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and  literature review.
    Alet M; Ciardi C; Alemán A; Bandeo L; Bonardo P; Cea C; Cirio J; Cossio J; Cuculic M; Esnaola MM; García-Pérez F; Giner F; Gómez-Schneider M; Isaac C; Lepera S; Martínez C; Martínez-Lorenzín R; Montes M; Orzuza G; Persi G; Povedano G; Pujol-Lereis V; Quiroga-Narváez J; Romano M; Sabio R; Viglione J; Zurrú MC; Saposnik G;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105145. PubMed ID: 32912503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
    Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
    JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis.
    Yaghi S; Saldanha IJ; Misquith C; Zaidat B; Shah A; Joudi K; Persaud B; Abdul Khalek F; Shu L; de Havenon A; Mistry EA; Bakradze E; Goldstein ED; Reagan J; Theodorou A; Palaiodimou L; Furie K; Field TS; Tsivgoulis G; Mac Grory B
    Stroke; 2022 Oct; 53(10):3014-3024. PubMed ID: 35938419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients.
    Geisbüsch C; Richter D; Herweh C; Ringleb PA; Nagel S
    Stroke; 2014 Aug; 45(8):2469-71. PubMed ID: 25070963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.